Could Europe’s Anti-Counterfeiting Pact be a “Pandora’s Box” of Rights...
Foggy details surrounding Europe’s anti-counterfeiting trade agreement (ACTA) have divided pubic opinion, with activists on one end of the spectrum claiming it to be the end of Internet freedom and the...
View ArticleIndia Poised to Supply Free Drugs to 1.2 Billion People
As the northern Indian state of Rajasthan rolls out an ambitious universal healthcare plan, the discontent of the state’s doctors stands in stark contrast to the joys of the 68 million people who will...
View ArticleBangladesh Eyes Drug Export Market
Bangladesh has begun to shed its image as one of the world’s poorest nations and make a reputation for itself as a major exporter of cheap generic drugs to over 85 countries. Listed by the United...
View ArticleBrazil Enters New Era of Co-Production of Anti-AIDS Drugs
A new kind of public-private partnership will begin in 2013 in Brazil to produce an antiretroviral drug, through a technology transfer agreement that will be in effect until the patent expires in 2017....
View ArticleThai-EU FTA Raises Alarm for People With AIDS
Days before leaders of the European Union (EU) arrived in Norway to collect this year’s Nobel Peace prize, Thai public health activists sent a letter to the northern powerhouse, warning that the EU’s...
View ArticleIndia’s Top Court Dismisses Drug Patent Case
India’s highest court has dismissed Swiss drug maker Novartis AG’s petition seeking patent protection for a cancer drug, a serious blow to Western pharmaceutical firms which are increasingly focusing...
View ArticleQ&A: A Healthy Verdict from India
India’s refusal to grant patent protection for the anti-cancer drug Glivec, developed by Swiss drugmaker Novartis, is a victory for the developing world, which depends on low-cost exports of generic...
View ArticleClik here to view.
U.S. Court Decision to Speed Introduction of Generic Drugs
"Pay to delay" agreements may cost consumers in the United States up to 3.5 billion dollars per year. Credit: BigstockThe Supreme Court pushed back Monday against a longstanding practise in the U.S....
View ArticleClik here to view.
Critics Warn Pacific Pact Could Jack Up Drug Costs
Intellectual property provisions proposed by the United States would extend monopoly powers derived from patents to pharmaceutical companies that sell their medicines abroad. Credit: BigstockAs a new...
View ArticleClik here to view.
Pacific Pact – a Minefield for Health Care
Patented drugs limit patients’ access to public health care. Credit: Kristin Palitza/IPSBy Emilio GodoyMEXICO CITY, Oct 8 2013 (IPS) The Trans Pacific Partnership Agreement (TPP), the negotiation of...
View ArticleClik here to view.
Changes Coming to South Africa’s Patent System
Patented drugs limit patients’ access to public health care. Credit: Kristin Palitza/IPSCAPE TOWN, South Africa, Dec 12 2013 (IPS) Paul Anley, chief executive officer of Pharma Dynamics, one of South...
View Article
